Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 1
2013 1
2014 2
2015 1
2019 1
2020 1
2021 1
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Improving the prognosis for lung cancer patients.
Clausen MM, Langer SW. Clausen MM, et al. Acta Oncol. 2019 Aug;58(8):1077-1078. doi: 10.1080/0284186X.2019.1632477. Epub 2019 Jul 1. Acta Oncol. 2019. PMID: 31257968 No abstract available.
[Canine cancer patients are included in translational research].
Børresen B, Clausen MM, Hansen AE, Zornhagen KW, Kristensen AT, Engelholm SA, Kjær A. Børresen B, et al. Among authors: clausen mm. Ugeskr Laeger. 2014 Jul 7;176(28):V01130041. Ugeskr Laeger. 2014. PMID: 25291999 Free article. Review. Danish.
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic.
Loft M, Christensen C, Clausen MM, Carlsen EA, Hansen CP, Kroman N, Langer SW, Høgdall C, Madsen J, Gillings N, Nielsen CH, Klausen TL, Holm S, Loft A, Berthelsen AK, Kjaer A. Loft M, et al. Among authors: clausen mm. J Nucl Med. 2022 Dec;63(12):1871-1879. doi: 10.2967/jnumed.122.264068. Epub 2022 May 19. J Nucl Med. 2022. PMID: 35589407 Clinical Trial.
Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with 18F-FDG PET/CT: A Single-Center Prospective Study.
Risør LM, Clausen MM, Ujmajuridze Z, Farhadi M, Andersen KF, Loft A, Friborg J, Kjaer A. Risør LM, et al. Among authors: clausen mm. J Nucl Med. 2022 Aug;63(8):1169-1176. doi: 10.2967/jnumed.121.262866. Epub 2021 Dec 2. J Nucl Med. 2022. PMID: 34857658 Free PMC article. Clinical Trial.
First-in-Human Study of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET for Integrin αvβ3 Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability.
Clausen MM, Carlsen EA, Christensen C, Madsen J, Brandt-Larsen M, Klausen TL, Holm S, Loft A, Berthelsen AK, Kroman N, Knigge U, Kjaer A. Clausen MM, et al. Diagnostics (Basel). 2022 Mar 30;12(4):851. doi: 10.3390/diagnostics12040851. Diagnostics (Basel). 2022. PMID: 35453899 Free PMC article.
Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study.
Clausen MM, Hansen AE, Lundemann M, Hollensen C, Pommer T, Munck Af Rosenschöld P, Kristensen AT, Kjær A, McEvoy FJ, Engelholm SA. Clausen MM, et al. Radiat Oncol. 2014 Oct 16;9:228. doi: 10.1186/s13014-014-0228-0. Radiat Oncol. 2014. PMID: 25319766 Free PMC article.
14 results